229.35
BATS BZX Real-Time Price
As of 12:37pm ET
 +2.96 / +1.31%
Today’s Change
216.12
Today|||52-Week Range
388.67
-23.78%
Year-to-Date
Biogen (BIIB) to Report Q1 Earnings: What's in the Cards?
10:58am / Zacks.com - Paid Partner Content
2 Beaten Down Bluechips: Are They Buys?
Apr 17 / MotleyFool.com - Paid Partner Content
Will Bristol-Myers (BMY) Disappoint This Earnings Season?
9:05am / Zacks.com - Paid Partner Content
Biogen (BIIB) Reports Next Week: Wall Street Expects Earnings Growth
Apr 17 / Zacks.com - Paid Partner Content
Roche's (RHHBY) Q1 Sales Strong on Solid Demand for New Drugs
Apr 18 / Zacks.com - Paid Partner Content
Biogen (BIIB) Dips More Than Broader Markets: What You Should Know
Apr 15 / Zacks.com - Paid Partner Content
2 Beaten-Down Blue Chips: Are They Buys?
Apr 17 / MotleyFool.com - Paid Partner Content
Better Buy: Gilead Sciences vs. Biogen
Apr 14 / MotleyFool.com - Paid Partner Content
Here's Why Ionis Pharmaceuticals Slumped Today
Apr 17 / MotleyFool.com - Paid Partner Content
Biogen (BIIB) Dips More Than Broader Markets: What You Should Know
Apr 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close226.39
Today’s open226.57
Day’s range226.57 - 232.17
Volume968,274
Average volume (3 months)1,993,482
Market cap$44.5B
Data as of 12:37pm ET, 04/22/2019

Growth & Valuation

Earnings growth (last year)+81.10%
Earnings growth (this year)+10.04%
Earnings growth (next 5 years)+2.30%
Revenue growth (last year)+9.67%
P/E ratio10.6
Price/Sales5.13
Price/Book3.42

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc-1.84-0.58%
EXASExact Sciences Corp+0.04+0.04%
GILDGilead Sciences-0.59-0.94%
BLUEbluebird bio Inc-2.34-1.71%
Data as of 12:38pm ET, 04/22/2019

Financials

Next reporting dateApril 24, 2019
EPS forecast (this quarter)$6.83
Annual revenue (last year)$12.1B
Annual profit (last year)$4.4B
Net profit margin36.76%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Chief Financial Officer &
Executive Vice President
Jeffrey D. Capello
Corporate headquarters
Cambridge, Massachusetts

Forecasts